open access

Vol 52, No 5 (2018)
Review article
Submitted: 2018-04-22
Get Citation

Which came first, the risk of migraine or the risk of asthma? A systematic review

Mehdi Sayyah, Amal Saki-Malehi, Fatemeh Javanmardi, Arash Forouzan, Kiarash Shirbandi, Fakher Rahim
DOI: 10.1016/j.pjnns.2018.07.004
·
Neurol Neurochir Pol 2018;52(5):562-569.

open access

Vol 52, No 5 (2018)
Review article
Submitted: 2018-04-22

Abstract

Objectives

We conducted this review to systematically assess the association and risk of the migraine in the patient with asthma and vice versa.

Methods

We systematically searched publishes articles indexed in PubMed, Scopus, Cochrane library, PsycINFO, CINAHL, ISI Web of Science, Science Direct from inception, and Embase databases until June 2017. The quality assessment of the involved studies was done using the Newcastle-Ottawa Scale (NOS).

Results

Eight studies with 389,573 participants were reviewed and selected for data extraction. Among the selected studies, 5 were reported the association between migraine with asthma risk, and the rest three studies reported the risk of asthma in patient with migraine compared to non-moraine individuals. Odds ratio (OR) of migraine for patient with asthma as compared with non-asthmatic individuals was 1.62 (95% CI 1.43–1.82). Data pooling using a random-effect model showed that migraine was associated with a significant increased risk of asthma (relative risk (RR): 1.56; 95% CI: 1.51–1.60; p < .00001). Besides, sub-group and sensitivity analyses supported the positive association between asthma and migraine, and risk of asthma in migraine patients.

Conclusion

Now it is unknown if control of the asthma will impact the severity of migraines or vice versa, but it is necessary to perform more research to further explain the mechanisms through which asthma increases the frequency of migraine or vice versa. If two conditions linked, once an individual undergo better control of asthma symptoms, might the excruciating migraine ease, too.

Abstract

Objectives

We conducted this review to systematically assess the association and risk of the migraine in the patient with asthma and vice versa.

Methods

We systematically searched publishes articles indexed in PubMed, Scopus, Cochrane library, PsycINFO, CINAHL, ISI Web of Science, Science Direct from inception, and Embase databases until June 2017. The quality assessment of the involved studies was done using the Newcastle-Ottawa Scale (NOS).

Results

Eight studies with 389,573 participants were reviewed and selected for data extraction. Among the selected studies, 5 were reported the association between migraine with asthma risk, and the rest three studies reported the risk of asthma in patient with migraine compared to non-moraine individuals. Odds ratio (OR) of migraine for patient with asthma as compared with non-asthmatic individuals was 1.62 (95% CI 1.43–1.82). Data pooling using a random-effect model showed that migraine was associated with a significant increased risk of asthma (relative risk (RR): 1.56; 95% CI: 1.51–1.60; p < .00001). Besides, sub-group and sensitivity analyses supported the positive association between asthma and migraine, and risk of asthma in migraine patients.

Conclusion

Now it is unknown if control of the asthma will impact the severity of migraines or vice versa, but it is necessary to perform more research to further explain the mechanisms through which asthma increases the frequency of migraine or vice versa. If two conditions linked, once an individual undergo better control of asthma symptoms, might the excruciating migraine ease, too.

Get Citation

Keywords

MOOSE, PRISMA, NOS, OR, RR, HR, CI

About this article
Title

Which came first, the risk of migraine or the risk of asthma? A systematic review

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 52, No 5 (2018)

Pages

562-569

DOI

10.1016/j.pjnns.2018.07.004

Bibliographic record

Neurol Neurochir Pol 2018;52(5):562-569.

Keywords

MOOSE
PRISMA
NOS
OR
RR
HR
CI

Authors

Mehdi Sayyah
Amal Saki-Malehi
Fatemeh Javanmardi
Arash Forouzan
Kiarash Shirbandi
Fakher Rahim

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl